Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2008

Feb 11, 2008

30339_dirs_2008-02-11_d4686ce9-ada4-4c2d-bb20-0d2cf7d39f0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-02-08

Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-08 Common Stock A 12.76 $37.97 Acquired 2517.7769 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 29808.1147 Direct
Common Stock 201.2663 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.